Evaluation of in vitro screening system for estrogenicity: Comparison of stably transfected human estrogen receptor-α transcriptional activation (OECD TG455) assay and estrogen receptor (ER) binding assay

Journal of Toxicological Sciences

Volumn 37, Issue 2, 2012, Pages 431-437

  Lee, Hae Kyung ^a   Kim, Tae Sung ^a   Kim, Chang Yeong ^a   Kang, Il Hyun ^a   Kim, Mi Gyeong ^a   Jung, Ki Kyung ^a   Kim, Hyung Sik ^b   Han, Soon Young ^a   Yoon, Hae Jung ^a   Rhee, Gyu Seek ^a  

^a National Institute of Food and Drug Safety Evaluation   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

4 nonylphenol; Bisphenol A; OECD test guideline 455; Phthalates; Tetrabromobisphenol A

Indexed keywords

BENZYLBUTYL PHTHALATE; DI(N BUTYL) PHTHALATE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DIETHYL ESTER; TETRABROMOBISPHENOL A; UNCLASSIFIED DRUG;

BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LETTER; NONHUMAN; YEAST;

EID: 84859297114     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.37.431     Document Type: Letter

References (24)

1. Akahori, Y., Nakai, M., Yamasaki, K., Tkatsuki, M., Shimohigashi, Y. and Ohtaki, M. (2008): Relationship between the results of in vitro receptor binding assay to human estrogen receptor α and in vivo uterotrophic assay: Comparative study with 65 selected chemicals. Toxicology In Vitro, 22, 225-231.
2. Andersen, H.R., Andersson, A.M., Arnold, S.F., Autrup, H., Barfoed, M., Beresford, N.A., Bjerregaard, P., Christiansen, L.B., Gissel, B., Hummel, R., Jørgensen, E.B., Korsgaard, B., Le Guevel, R., Leffers, H., McLachlan, J., Møller, A., Nielsen, J.B., Olea, N., Oles-Karasko, A., Pakdel, F., Pedersen, K.L., Perez, P., Skakkeboek, N.E., Sonnenschein, C., Soto, A.M., Sumpter, J.P., Thorpe, S.M. and Grandjean, P. (1999): Comparison of shortterm estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect., 107, 89-108.
3. Bonefeld-Jørgensen, E.C., Long, M., Hofmeister, M.V., and Vinggaard, A.M. (2007): Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ. Health Perspect., 115, 69-76.
4. Colborn, T., vom Saal, F.S. and Soto, A.M. (1993): Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect., 101, 378-384.
5. Coldham, N.G., Dave, M., Sivapathasundaram, S., McDonnell, D.P., Connor, C. and Sauer, M.J. (1997): Evaluation of a recombinant yeast cell estrogen screening assay. Environ. Health Perspect., 105, 734-742.
6. Dang, Z., Ru, S., Wang, W., Rorije, E., Hakkert, B. and Vermeire, T. (2011): Comparison of chemical-induced transcriptional activation of fish and human estrogen receptors: Regulatory implications. Toxicol. Lett., 201, 152-175.
7. Fang, H., Tong, W., Perkins, R., Soto, A.M., Prechtl, N.V. and Sheehan, D.M. (2000): Quantitative comparisons of in vitro assays for estrogenic activities. Environ. Health Perspect., 108, 723-729.
8. Hunter, D.S., Hodges, L.C., Vonier, P.M., Fuchs-Young, R., Gottardis M.M. and Walker, C.L. (1999): Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res., 59, 3090-3099.
9. Jobling, S., Reynolds, T., White, R., Parker, M.G. and Sumpter, J.P. (1995): A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect., 103, 582-587.
10. Kolle, S.N., Kamp, H.G., Huener, H.A., Knickel, J., Verlohner, A., Woitkowiak, C., Landsiedel, R. and van Ravenzwaay, B. (2010): In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays. Toxicol. In Vitro, 24, 2030-2040.
11. Miller, D., Wheals, B.B., Beresford, N. and Sumpter, J.P. (2001): Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay. Environ. Health Perspect., 109, 133-138.
12. Nakai, M., Tabira, Y., Asai, D., Yakabe, Y., Shimyozu, T., Noguchi, M., Takatsuki, M. and Shimohigashi, Y. (1999): Binding characteristics of dialkyl phthalates for the estrogen receptor. Biochem. Biophys. Res. Commun., 254, 311-314.
13. OECD, Organization for Economic Cooperation and Development. (2003): Draft summary report of the sixth meeting of the task force on endocrine disrupters testing and assessment (EDTA 6). Paris.
14. OECD, Organization for Economic Cooperation and Development. (2009): Ten new test guidelines and six updated test guidelines have been adopted by council on 7 September.
15. Picard, K., Lhuguenot, J.C., Lavier-Canivenc, M.C. and Chagnon, M.C. (2001): Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: Identification of the active molecule(s). Toxicol. Appl. Pharmacol., 172, 108-118.
16. Routledge, E.J. and Sumpter, J.P. (1997): Structural features of alkylphenolic chemicals associated with estrogenic activity. J. Biol. Chem., 272, 3280-3288.
17. Seidlová-Wuttke, D., Jarry, H., Christoffel, J., Rimoldi, G. and Wuttke, W. (2005): Effects of bisphenol-A (BPA), dibutylphtalate (DBP), benzophenone-2 (BP2), procymidone (Proc), and linurone (Lin) on fat tissue, a variety of hormones and metabolic parameters: A 3 months comparison with effects of estradiol (E2) in ovariectomized (ovx) rats. Toxicology, 213, 13-24.
18. Soto, A.M., Sonnenschein, C., Chung, K.L., Fernandez, M.F., Olea, N. and Serrano, F.O. (1995): The E-screen assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect., 103, 113-122.
19. Stasinakis, A.S., Petalas, A.V., Mamais, D. and Thomaidis, N.S. (2008): Application of the OECD 301F respirometric test for the biodegradability assessment of various potential endocrine disrupting chemicals. Bioresour. Technol., 99, 3458-3467.
20. Takeuchi, S., Iida, M., Kobayashi, S., Jin, K., Matsuda, T. and Kojima, H. (2005): Differential effects of phthalate esters on transcriptional activities via human estrogen receptors α and β,and androgen receptor. Toxicology, 210, 223-233.
21. van den Belt, K., Berckmans, P., Vangenechten C., Verheyen, R. and Witters, H. (2004): Comparative study on the in vitro/in vivo estrogenic potencies of 17beta-estradiol, estrone, 17alpha-ethynylestradiol and nonylphenol. Aquat. Toxicol., 66, 183-195.
22. Vos, J.G., Dybing, E., Greim, H.A., Ladefoged, O., Lambré, C., Tarazona, J.V., Brandt, I. and Vethaak, A.D. (2000): Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European situation. Crit. Rev. Toxicol., 30, 71-133.
23. Yamasaki, K., Noda, S., Imatanaka, N. and Yakabe, Y. (2004): Comparative study of the uterotrophic potency of 14 chemicals in a uterotrophic assay and their receptor-binding affinity. Toxicol. Lett., 146, 111-120.
24. Zacharewski, T.R., Meek, M.D., Clemons, J.H., Wu, Z.F., Fielden, M.R. and Matthews, J.B. (1998): Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol. Sciences., 46, 282-293.